| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Departments of
*
Molecular Genetics and Biochemistry and
Cell Biology and Physiology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261
Immunity to tumor Ags in patients is typically weak and not therapeutic. We have identified a new mechanism by which potentially immunogenic glycoprotein tumor Ags, such as MUC1, fail to stimulate strong immune responses. MUC1 is a heavily glycosylated membrane protein that is also present in soluble form in sera and ascites of cancer patients. We show that this soluble protein is readily taken up by dendritic cells (DC), but is not transported to late endosomes or MHC class II compartments for processing and binding to class II MHC. MUC1 uptake is mediated by the mannose receptor, and the protein is then retained long term in early endosomes without degradation. Long-term retention of MUC1 does not interfere with the ability of DC to process and present other Ags. We also demonstrate inhibited processing of another important glycoprotein tumor Ag, HER-2/neu. This may, therefore, be a frequent obstacle to presentation of tumor Ags and an important consideration in the design of cancer vaccines. It should be possible to overcome this obstacle by providing DC with a form of tumor Ag that can be better processed. For MUC1 we show that a 140-aa-long synthetic peptide is very efficiently processed by DC.
This article has been cited by other articles:
|
|
 |
|
  T. L. Tinder, D. B. Subramani, G. D. Basu, J. M. Bradley, J. Schettini, A. Million, T. Skaar, and P. Mukherjee MUC1 Enhances Tumor Progression and Contributes Toward Immunosuppression in a Mouse Model of Spontaneous Pancreatic Adenocarcinoma J. Immunol., September 1, 2008; 181(5): 3116 - 3125. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Kadaoui and B. Corthesy Secretory IgA Mediates Bacterial Translocation to Dendritic Cells in Mouse Peyer's Patches with Restriction to Mucosal Compartment J. Immunol., December 1, 2007; 179(11): 7751 - 7757. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Napoletano, A. Rughetti, M. P. Agervig Tarp, J. Coleman, E. P. Bennett, G. Picco, P. Sale, K. Denda-Nagai, T. Irimura, U. Mandel, et al. Tumor-Associated Tn-MUC1 Glycoform Is Internalized through the Macrophage Galactose-Type C-Type Lectin and Delivered to the HLA Class I and II Compartments in Dendritic Cells Cancer Res., September 1, 2007; 67(17): 8358 - 8367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ninkovic and F.-G. Hanisch O-Glycosylated Human MUC1 Repeats Are Processed In Vitro by Immunoproteasomes J. Immunol., August 15, 2007; 179(4): 2380 - 2388. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Sangha and C. Butts L-BLP25: A Peptide Vaccine Strategy in Non Small Cell Lung Cancer Clin. Cancer Res., August 1, 2007; 13(15): 4652s - 4654s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. L. Beatty, S. E. Plevy, A. R. Sepulveda, and O. J. Finn Cutting Edge: Transgenic Expression of Human MUC1 in IL-10-/- Mice Accelerates Inflammatory Bowel Disease and Progression to Colon Cancer J. Immunol., July 15, 2007; 179(2): 735 - 739. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Turner, P. A. Cohen, and O. J. Finn Lack of Effective MUC1 Tumor Antigen-Specific Immunity in MUC1-Transgenic Mice Results from a Th/T Regulatory Cell Imbalance That Can Be Corrected by Adoptive Transfer of Wild-Type Th Cells J. Immunol., March 1, 2007; 178(5): 2787 - 2793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 U. Meltzer and D. Goldblatt Pneumococcal Polysaccharides Interact with Human Dendritic Cells Infect. Immun., March 1, 2006; 74(3): 1890 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. G. Wahrenbrock and A. Varki Multiple Hepatic Receptors Cooperate to Eliminate Secretory Mucins Aberrantly Entering the Bloodstream: Are Circulating Cancer Mucins the "Tip of the Iceberg"? Cancer Res., February 15, 2006; 66(4): 2433 - 2441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. von Mensdorff-Pouilly, L. Kinarsky, K. Engelmann, S. E. Baldus, R. H. Verheijen, M. A. Hollingsworth, V. Pisarev, S. Sherman, and F.-G. Hanisch Sequence-variant repeats of MUC1 show higher conformational flexibility, are less densely O-glycosylated and induce differential B lymphocyte responses Glycobiology, August 1, 2005; 15(8): 735 - 746. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Carlos, H. F. Dong, O. M. Z. Howard, J. J. Oppenheim, F.-G. Hanisch, and O. J. Finn Human Tumor Antigen MUC1 Is Chemotactic for Immature Dendritic Cells and Elicits Maturation but Does Not Promote Th1 Type Immunity J. Immunol., August 1, 2005; 175(3): 1628 - 1635. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Napper and M. E. Taylor The mannose receptor fails to enhance processing and presentation of a glycoprotein antigen in transfected fibroblasts Glycobiology, October 1, 2004; 14(10): 7C - 12C. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Monti, B. E. Leone, A. Zerbi, G. Balzano, S. Cainarca, V. Sordi, M. Pontillo, A. Mercalli, V. Di Carlo, P. Allavena, et al. Tumor-Derived MUC1 Mucins Interact with Differentiating Monocytes and Induce IL-10highIL-12low Regulatory Dendritic Cell J. Immunol., June 15, 2004; 172(12): 7341 - 7349. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jackaman, C. S. Bundell, B. F. Kinnear, A. M. Smith, P. Filion, D. van Hagen, B. W. S. Robinson, and D. J. Nelson IL-2 Intratumoral Immunotherapy Enhances CD8+ T Cells That Mediate Destruction of Tumor Cells and Tumor-Associated Vasculature: A Novel Mechanism for IL-2 J. Immunol., November 15, 2003; 171(10): 5051 - 5063. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Schlienger, C. S. Chu, E. Y. Woo, P. M. Rivers, A. J. Toll, B. Hudson, M. V. Maus, J. L. Riley, Y. Choi, G. Coukos, et al. TRANCE- and CD40 Ligand-matured Dendritic Cells Reveal MHC Class I-restricted T Cells Specific for Autologous Tumor in Late-Stage Ovarian Cancer Patients Clin. Cancer Res., April 1, 2003; 9(4): 1517 - 1527. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Vlad, S. Muller, M. Cudic, H. Paulsen, L. Otvos Jr., F.-G. Hanisch, and O. J. Finn Complex Carbohydrates Are Not Removed During Processing of Glycoproteins by Dendritic Cells: Processing of Tumor Antigen MUC1 Glycopeptides for Presentation to Major Histocompatibility Complex Class II-restricted T Cells J. Exp. Med., December 2, 2002; 196(11): 1435 - 1446. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Higashi, A. Morikawa, K. Fujioka, Y. Fujita, Y. Sano, M. Miyata-Takeuchi, N. Suzuki, and T. Irimura Human macrophage lectin specific for galactose/N-acetylgalactosamine is a marker for cells at an intermediate stage in their differentiation from monocytes into macrophages Int. Immunol., June 1, 2002; 14(6): 545 - 554. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sarkar, V. Kalia, M. Murphey-Corb, and R. C. Montelaro Detailed Analysis of CD4+ Th Responses to Envelope and Gag Proteins of Simian Immunodeficiency Virus Reveals an Exclusion of Broadly Reactive Th Epitopes from the Glycosylated Regions of Envelope J. Immunol., April 15, 2002; 168(8): 4001 - 4011. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Heystek, C. Moulon, A. M. Woltman, P. Garonne, and C. van Kooten Human Immature Dendritic Cells Efficiently Bind and Take up Secretory IgA Without the Induction of Maturation J. Immunol., January 1, 2002; 168(1): 102 - 107. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schmielau and O. J. Finn Activated Granulocytes and Granulocyte-derived Hydrogen Peroxide Are the Underlying Mechanism of Suppression of T-Cell Function in Advanced Cancer Patients Cancer Res., June 1, 2001; 61(12): 4756 - 4760. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Soares, V. Mehta, and O. J. Finn Three Different Vaccines Based on the 140-Amino Acid MUC1 Peptide with Seven Tandemly Repeated Tumor-Specific Epitopes Elicit Distinct Immune Effector Mechanisms in Wild-Type Versus MUC1-Transgenic Mice with Different Potential for Tumor Rejection J. Immunol., June 1, 2001; 166(11): 6555 - 6563. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Nelson, S. Mukherjee, C. Bundell, S. Fisher, D. van Hagen, and B. Robinson Tumor Progression Despite Efficient Tumor Antigen Cross-Presentation and Effective "Arming" of Tumor Antigen-Specific CTL J. Immunol., May 1, 2001; 166(9): 5557 - 5566. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
